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Abstract. In this paper, we provide an empirical framework to analyze the macroeconomic
effects of public health expenditure in the US. In particular, a computable general equilibrium
(CGE) model called GTAP-HE, has been developed and applied to include predicted variations in
public health expenditure. Although the framework employed in the paper is highly specialized
and may not hold generally, results provide relevant information on the relationship of health
public expenditure and macroeconomic effects. Our main findings show that an increasing public
expenditure is associated with a decrease in GDP and welfare and a positive effect on trade. We
also find an increase in employment level in non-market services sector, which includes health,
defense, education and public administration. The robustness of the results has been tested over
time for the period 2010-2018. The main policy recommendation that can be drawn from the
results is that the health expenditure policy needs to be coupled with labour and trade policies.
JEL Classification Numbers: D58, H51, I11.
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1. Introduction
The interactions between health care expenditure and the remainder of the economy are multi-
ple and complex. On the one hand, changes in income affect the consumption and the provision of
health care; on the other hand, changes in health by variations in health care expenditure affect the
well-being of populations, such as employment, productivity and income. The interdependencies
between health care, health and the rest of the economy have been widely studied in the economic
literature. 1 The traditional empirical approach used in these studies relies deeply on econometric
models, that focus on multiple linkages between health expenditures and economic growth. Dif-
ferently, this paper is a first attempt to analyze the general equilibrium effects of changes in public
health expenditure, which aspects have been neglected in literature. In fact, there is a limited
number of studies on computable general equilibrium (CGE) models in this application area, that
have been mainly concentrated on coupling health and CGE models (see for example, Lee and
McKibbin [24], Dixon et al. [16], Smith et al.[29]). Only recently, Bosello et al.[12] and Rutten
and Reed [27] report some results of the effects on health expenditure using CGE models, but the
aims of their studies differ from the aim of this paper. In fact, Bosello et al.[12]study the economic
impact of climate change induced change in human health as change in labour productivity and
demand for health care. Rutten and Reed [27] determine the macroeconomic impacts of change
in health care provision under the assumption of different resource allocations.
The main contribution of our paper is empirical. It tries to offer policy recommendations
taking as case study the US. We analyse the effects of change in public health expenditure on
macroeconomic indicators, such as employment, GDP, trade and welfare, over a full projection
period (2010-2018). For this, a computable general equilibrium (CGE) model, called GTAP-HE,
has been developed to include the predicted variations in the public health expenditure. Data from
Date: September 4, 2009.
1Bhargava et al. [2], Bloom and Canning [7], Bloom et al. [8]-[9]-[10], Cre´mieux et al. [14], Hamoudi and Sachs
[17], Hitiris and Posnett [19], Jamison et al. [20], Knowles and Owen [23], Pritchett and Summers [26], Strauss
and Thomas [30], Stronks et al. [31] and Thomas [32].
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the National Health Expenditure Accounts (NHEA) for 2010-2018, computed by the Department
of Health and Human Services have been used to simulate the scenarios.
Although the framework employed in the paper is highly specialized and may not hold generally,
results provide relevant information on the relationship of public expenditure and macroeconomic
effects. In fact, if on the one hand, on a microeconomic point of view, public health expenditure is
usually sustained in order to increase the health service coverage and the health system resources,
as well as to reduce inequities in health care, mortality and risk factors. On the other hand,
in macroeconomic terms, an increase of public health expenditure may have negative effects on
welfare and GDP. The main policy recommendation that can be drawn from the results is that
the health expenditure policy needs to be coupled with labour and trade policies.
The structure of the paper is as follows. Section 2 explains the modeling framework. Section
3 presents scenarios and data set. Section 4 discusses the simulation results. The final section
concludes and suggests directions for future research.
2. Modeling framework
In order to assess the macroeconomic effects of public health expenditure in the US, a com-
putable general equilibrium (CGE) model, called GTAP-HE, has been developed and applied.
CGE models build upon general equilibrium theory that combines behavioral assumptions on
rational economic agents with the analysis of equilibrium conditions. Since the first CGE ap-
plication by Johansen [21], CGE models have been widely employed by various national and
international organizations (IMF, World Bank, OECD, etc.), research institutions and universi-
ties. For survey articles see, e.g. Bhattacharyya [3], Bergman et al. [4], Borges [11], Conrad [13],
Shoven and Whalley [28]. In order to analyze the impact of a policy change, the CGE modelers
use the comparative methodology. Initially, the CGE model is developed such that its equilib-
rium replicates the transactions observed in the data. This procedure, called calibration, refers
to the estimation of structural parameters of the model, based on available information on prices
and quantities, normally, obtained from a Social Accounting Matrix (SAM). Moreover, the policy
change is simulated by altering the relevant parameters and calculating the new equilibrium.
GTAP-HE is a refinement of the GTAP model, which is a comparative static, multi-commodity,
multi-region CGE model with the assumptions of perfect competition and market equilibrium
(Hertel [18]). The original GTAP model has been widely used and modified for analyzing the
impacts of economic growth (Jorgenson [22] ), international trade (Devarajan et al. [15]; Markusen
et al., [25]) and environmental policies (Berrittella et al. [6]). We apply GTAP-HE by aggregating
the US’s economy into five industries (Table 1): Agriculture, Energy, Market Services, Non-market
Services, Other Industries. Commonly to the standard GTAP, industries are modeled through a
representative firm minimizing costs and taking prices as given. The production functions are
specified via a series of nested constant elasticity of substitution (CES) functions such that:
yi = (
∑n
j=1
θjx
σ−1
σ
j )
σ
σ−1 (1)
where yi is the production of the good i, xj is the input j, θj is a weighting parameter, with∑
j θj = 1, and σ is the elasticity of substitution.
Each primary factor (Labor, Capital, Land and Natural Resources) is supplied to industries from
its fixed regional endowment. Labor and capital are perfectly mobile endowments earning the same
market return. Land and natural resources are sluggish endowments to adjust and, hence, they
sustain differential returns in equilibrium. Domestic and foreign inputs are not perfect substitutes,
according to the so called “Armington assumption” (Armington [1]), which accounts for product
heterogeneity.
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A representative household receives income, which is used to finance three classes of expenditure:
private consumption, public consumption and savings. Her utility function is specified by a Cobb-
Douglas structure. A constant-difference-elasticity (CDE) utility function is used for determining
private consumption. Public consumption is determined by the maximization of a Cobb-Douglas
utility function. However, almost all public expenditure is concentrated in one specific industry:
Non-market Services. Both public and private consumption is split in a series of alternative
composite Armington aggregates.
All these elements are linked by the concept of equilibrium, which is satisfied under the following
properties: (i) supply equals demand for each produced good or service; (ii) supply equals demand
in each factor market.
In GTAP-HE, the impact of public health expenditure is modeled by means of changes in
the structure of public consumption. In more details, the affected variable is the public domestic
expenditure of non-market services, as the health industry is a sub-industry of non-market services.
Using the linearized representation, in the original GTAP model, the percentage change in public
domestic demand is given by:
qgdi = qgi + µi(pgi − pgdi) (2)
where qgdi is the public demand for domestic commodity i, qgi is the public demand for com-
modity i, µi is the elasticity of substitution between domestic and imported goods, pgi is the
public consumption price for commodity i and pgdi is the public consumption price for domestic
commodity i.
Since consumption levels, including those of non-market services are endogenous variables in
the original GTAP model, following the lead of Bosello et al.[12], we introduce a shift parameter
in GTAP-HE, which yields the required exogenous change in public health expenditure if all prices
and income levels would stay constant. Thus, the percentage change in public domestic demand
becomes:
qgdi = agdi + qgi + µi(pgi − pgdi) (3)
where agdi is the exogenous change of the public demand for domestic commodity i.
When these shocks agdi are simulated in a general equilibrium framework, the model allows the
US’s economy to adapt to the shocks. Furthermore, in order to comply with budget constraints
and the Walras’s law, public expenditure shares in other sectors are rebalanced, by means of
counteracting reductions for consumption items not related to health. This does not affect the
equilibrium interpretation of the shocks on expenditures for non-market services.
3. Design of scenarios and data
We use data from the National Health Expenditure Accounts (NHEA) for 2010-2018, computed
by the Department of Health and Human Services with the aim of measuring the total amount
spent in the United States to purchase health care goods and services during the year. This data
are particularly suitable for our purpose since the NHEA contains all of the main components of
the health care system within a unified structure and it also provides the source funding these
expenditures. The NHEA bring into focus the share and magnitude of public and private spending
for various range of health expenditure providing also projections of what health care expenditures
will be in future.2 In this paper we focus on public health expenditure, that is the annual percent
change from previous year of Federal and StateLocal health spending including both Medicaid
and Medicare. Table 2 reports the scenarios, that is the variation in public health expenditure
over the full projection period 2010-2018.
2Projections are based on NHEA historical data and are estimates of spending for health care in the U.S. over the
next decade by type of service delivered (hospital care, physician services, etc.) and by source of funding (Keehan
et al. [?].
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The approach to simulate the scenarios is based on a two-stage procedure. Firstly, counterfactual
equilibria of the world economy are generated by “pseudo-calibration” from 1997 over the full
projection period (2010-2018). This entails changing the initial calibration data in the model to
forecasted values of some key economic variables for the projection period. The calibration data
comes from the GTAP database, version 5, that contains the 1997 world economy data. The
forecasted values for the projection period include estimates of population growth, endowments
change of labour, capital and natural resources, productivity change of labor and land. The
resulting scenario is called “benchmark”.3 Subsequently, conventional comparative analysis of
public health expenditure in the US is conducted simulating the scenarios over the full projection
period (2010-2018).
4. Simulation results
This section reports the macroeconomic effects of the public health expenditure in the US in
terms of variations from the benchmark equilibrium over the full projection period (2010-2018).
Table 2 shows that shifts in public domestic demand for non-market services are slightly different
before and after the simulations. This is due to the general equilibrium effects: the initial variation
is higher than the expenditure variation observed in equilibrium, because the US’s economy reacts
to these shifts in non-market services demand by means of adjustments in price and income levels,
which allow the system to attain a new general equilibrium.
Although, the public health expenditure in US increases, the final effect on the public expendi-
ture is negative (Table 3). In fact, higher public demand for health induces to decrease the public
demand on other consumption items.
Production level increases only for non-market services due to the increase of public health
expenditure (Table 4). This yields an increase of employment in non-market services increases
(Table 3). As supply of primary factors is fixed in the short run, a demand shift towards labour-
intensive services, such as health, implies that the final effect on wages is positive (Figure 1).
Furthermore, the production shift to labour-intensive sectors implies a reduction in import. The
coupling of the decrease in import of non-market services with the substantial increase of exports
by other industries yields positive effects on trade balance (Table 5). However, this would lead to
a negative welfare change (Figure 2). Decomposing the welfare change in its components, Figure
2 shows that contribution of terms of trade to welfare change (expressed in terms of equivalent
variation) is decreasing, and contribution of allocative effects to welfare change is increasing over
time. This is due to the endowment distribution change. The effect of public health expenditure
on GDP is negative, but it is not too much significant (Figure 3).
Comparing the results over the full projection period (2010-2018), in terms of magnitude, the
relative ranking of the initial shocks does not always coincide with the relative ranking of GDP,
welfare and trade. This is due to the fact that public health expenditure growth is not linear to
the forecasted values for population growth, endowments and productivity change applied for the
”pseudo-calibration” (or benchmark) scenarios. Furthermore, the main policy recommendation
that can be drawn from the results is that in order to reduce the welfare and GDP loss, the health
expenditure policy needs to be coupled with labour policy that affect the endowment distribution
such that to reduce slightly the increase of employment in labour-intensive sectors, and trade
policy, that decreases further the import tariffs.
5. Discussion and conclusions
This paper has attempted to discuss preliminary results on the macroeconomic effects of public
health expenditure in the US. A multi-country, multi-region CGE model, called GTAP-HE, has
3These estimate values have been previously used for analyzing different policy issues, such as sustainability (Zhang
et al.[33]) and public investment (Berrittella [5])
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been developed to include the predicted variation in public health expenditure. On a microeco-
nomic point of view, public health expenditure is usually sustained in order to increase the health
service coverage and the health system resources, as well as to reduce inequities in health care,
mortality and risk factors. However, the results in this paper suggest that there is a linkage be-
tween macroeconomic and health indicators that must be taken into account in evaluating health
policy. But, in macroeconomic terms, an increase of public health expenditure have negative ef-
fects on welfare and GDP. These effects could be reduced by coupling trade and labour policies
to health expenditure policy.
The GTAP-HE model employed in the paper may become particularly relevant for health policy
if it is applied in developing countries. However, the GTAP-HE model suffers from a number of
drawbacks and research on this topic merits to be extended to include at least four issues in GTAP-
HE. Firstly indicators related to health service coverage, the health system resources, inequities
in health care, mortality, burden of disease and risk factors. Secondly, health models, such that
to obtain an integrated health assessment. Thirdly, determinants of health demand, that may
affect labour supply, productivity and population level. Finally, intragroup income distributional
change; in fact, any analysis of the impact of any health policy scenario should take into account
it, because health impacts are likely to affect many socioeconomic groups at varying degree.
Appendix A. Parameters’ estimates
Table 1. Industry aggregation
Industry Sectors
Agriculture (Agr) Paddy rice, Wheat, Cereal grains, crops, Vegetables, fruit, nuts,
oil seeds, sugar cane and beet, plant-based fibres, Cattle, sheep,
goats, horses, animal products, Forestry, Fishing
Energy (Energy Ind) Coal, Oil, Gas, gas manufacture and distribution, Petroleum,
coal products, Electricity, Energy Intensive Industries (Miner-
als, chemical, rubber, plastic products, mineral products, fer-
rous metals, metals)
Market Services (MServ) Construction, trade, surface transport, sea transport, air trans-
port, communication, financial services, insurance, business ser-
vices, dwellings, recreation and other services
Non-market Services (NMServ) Public administration, defence, health and education
Other Industries (Oth Ind) Raw milk, wool, silk-worm cocoons, meat, vegetable oils and
fat, dairy products, processed rice, sugar, food products, bev-
erages and tobacco products, textiles, wearing apparel, leather
products, wood products, paper products, publishing, metals
products, motor vehicles and parts, transport equipment, elec-
tronic equipment, machinery, manufactures, water distribution
services
Table 2. Public domestic demand for non-market services (% change w.r.t. bench-
mark scenario)
Initial variation Equilibrium
2010 5 4.948
2012 6.9 6.831
2014 7.4 7.328
2016 7.9 7.825
2018 8.2 8.125
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Table 3. Social indicators (% change w.r.t. benchmark scenario)
Public expenditure Public expenditure as %
of GDP
Employment in
non-market services
2010 -0.0233 -0.0228 1.59
2012 -0.0306 -0.0304 2.20
2014 -0.0311 -0.0309 2.37
2016 -0.0315 -0.0307 2.54
2018 -0.0313 -0.0307 2.65
Table 4. Production levels ((% change w.r.t. benchmark scenario))
2010 2012 2014 2016 2018
Agriculture -0.18 -0.27 -0.30 -0.33 -0.36
Energy -0.06 -0.09 -0.09 -0.10 -0.11
Market Services -0.40 -0.56 -0.59 -0.63 -0.66
Non-market Services 1.64 2.28 2.45 2.62 2.73
Other industries -0.41 -0.58 -0.63 -0.68 -0.72
Table 5. Terms of trade (Mln $ change w.r.t. benchmark scenario)
2010 2012 2014 2016 2018
Agriculture 149 239 292 349 402
Energy 818 1262 1487 1714 1919
Market Services 596 857 938 994 1034
Non-market Services -28 -57 -83 - 116 -147
Other industries 2558 3725 4166 4561 4910
Total 4093 6027 6800 7501 8119
Figure 1. Wages (% change w.r.t. benchmark scenario)
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Figure 2. Welfare effects (Mln $ change w.r.t. benchmark scenario)
Figure 3. Change in GDP as function of the change in the public health demand
((Mln $ change w.r.t. benchmark scenario))
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